Scholarlink

<p>Ischemic stroke presents a dual therapeutic challenge, involving dynamic and compartmentalized pathology in both the peripheral immune system and the central nervous system. Departing from conventional holistic treatment strategies, we developed a spatially tiered drug delivery approach using a combination of dual-stiffness nanoparticles (NPs) for compartment-specific therapy. Exploiting stiffness-dependent biodistribution, stiff NPs preferentially targeted peripheral immune cells, delivering anti-inflammatory agents to attenuate systemic inflammation and prevent immune cell infiltration into the brain. In parallel, soft NPs, shielded from immune uptake, efficiently penetrated the brain to deliver neuroprotectants and restore the damaged neural microenvironment. Mechanistic studies indicate that this selective distribution arises from the interplay between NP stiffness-dependent membrane energetics and competitive serum protein adsorption. This mechano-guided delivery strategy achieves synergistic “peripheral-central” intervention via a single administration, establishing a paradigm for precision nanomedicine, with broad potential in treating multi-compartment pathologies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dual-stiffness nanoparticles for compartment-specific drug delivery in stroke

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月12日

查看全文
  • Hui Liu,
  • Juanjuan Zheng,
  • Yaosheng Li,
  • Rouxuan Wang,
  • Zefeng Yang,
  • Yunfei Dong,
  • Yuankai Sun,
  • Zhiwei Du,
  • Liang Pei,
  • Xiaoyu Qiu,
  • Bo Zhao,
  • Lu Li,
  • Jiahe Wu,
  • Xuejin Li,
  • Xinchi Jiang,
  • Chun-Xia Zhao,
  • Jianqing Gao

摘要

Ischemic stroke presents a dual therapeutic challenge, involving dynamic and compartmentalized pathology in both the peripheral immune system and the central nervous system. Departing from conventional holistic treatment strategies, we developed a spatially tiered drug delivery approach using a combination of dual-stiffness nanoparticles (NPs) for compartment-specific therapy. Exploiting stiffness-dependent biodistribution, stiff NPs preferentially targeted peripheral immune cells, delivering anti-inflammatory agents to attenuate systemic inflammation and prevent immune cell infiltration into the brain. In parallel, soft NPs, shielded from immune uptake, efficiently penetrated the brain to deliver neuroprotectants and restore the damaged neural microenvironment. Mechanistic studies indicate that this selective distribution arises from the interplay between NP stiffness-dependent membrane energetics and competitive serum protein adsorption. This mechano-guided delivery strategy achieves synergistic “peripheral-central” intervention via a single administration, establishing a paradigm for precision nanomedicine, with broad potential in treating multi-compartment pathologies.